HOME › DRUGS › DENGUE TETRAVALENT VACCINE (LIVE, ATTENUATED)
ACTIVE SUBSTANCE / INN

DENGUE TETRAVALENT VACCINE (LIVE, ATTENUATED)

Brand name(s): Qdenga, Dengvaxia
EMA LISTED
WITHDRAWN
AUTHORISED
Dengue
ACTIVE SUBSTANCE
Dengue Tetravalent Vaccine (Live, Attenuated)
REGULATORS
EMA
SPONSORS / MAH
Takeda Pharmaceuticals International AG Ireland Branch, Sanofi Winthrop Industrie
TOTAL APPLICATIONS
2
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
QdengaTakeda Pharmaceuticals International AG Ireland BranchAuthorised05/12/2022Dengue
DengvaxiaSanofi Winthrop IndustrieWithdrawn12/12/2018Dengue

FULL INTELLIGENCE ON DENGUE TETRAVALENT VACCINE (LIVE, ATTENUATED)

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →